QRG Capital Management Inc. Buys 2,234 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

QRG Capital Management Inc. increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 3.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 75,076 shares of the medical equipment provider's stock after purchasing an additional 2,234 shares during the period. QRG Capital Management Inc.'s holdings in Intuitive Surgical were worth $37,183,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Atala Financial Inc acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $25,000. Parvin Asset Management LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter valued at $26,000. Global Financial Private Client LLC grew its position in Intuitive Surgical by 253.3% during the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after acquiring an additional 38 shares during the last quarter. BankPlus Trust Department acquired a new position in Intuitive Surgical in the 4th quarter worth about $28,000. Finally, Hurley Capital LLC bought a new stake in shares of Intuitive Surgical in the fourth quarter worth $28,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Price Performance

NASDAQ ISRG traded up $6.86 on Monday, reaching $519.04. 1,513,774 shares of the company's stock traded hands, compared to its average volume of 1,675,178. The stock has a market cap of $186.03 billion, a PE ratio of 80.97, a P/E/G ratio of 5.85 and a beta of 1.67. Intuitive Surgical, Inc. has a 12 month low of $413.82 and a 12 month high of $616.00. The stock has a 50-day simple moving average of $526.57 and a 200 day simple moving average of $538.46.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The company had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. During the same quarter last year, the company earned $1.50 EPS. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on ISRG. Truist Financial lowered their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a report on Wednesday, April 23rd. BTIG Research set a $560.00 price target on shares of Intuitive Surgical and gave the company a "buy" rating in a research report on Monday, April 14th. Deutsche Bank Aktiengesellschaft lowered Intuitive Surgical from a "hold" rating to a "sell" rating and lowered their price objective for the stock from $515.00 to $440.00 in a research report on Monday, June 9th. Barclays lowered their target price on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a report on Thursday, April 24th. Finally, Royal Bank of Canada reduced their target price on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $588.95.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Gary Loeb sold 1,700 shares of the company's stock in a transaction that occurred on Friday, April 25th. The stock was sold at an average price of $513.18, for a total transaction of $872,406.00. Following the transaction, the executive vice president now owns 2,245 shares in the company, valued at approximately $1,152,089.10. This represents a 43.09% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Mark Brosius sold 215 shares of the firm's stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $549.06, for a total value of $118,047.90. Following the completion of the transaction, the senior vice president now owns 1,768 shares of the company's stock, valued at approximately $970,738.08. The trade was a 10.84% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 4,998 shares of company stock worth $2,611,577. Company insiders own 0.70% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.